Business / Corporate Oct 16, 2020
Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
The move comes after a late-stage study showed reduced recovery times for patients with nonsevere symptoms.
Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
The move comes after a late-stage study showed reduced recovery times for patients with nonsevere symptoms.
Two shots being developed by CNBG which are still in the final, third phase of testing have been authorized for emergency use in the country.
Japan pledges $130 million for fair access to COVID-19 vaccines
The country has already extended more than $1.54 billion worth of aid to fight the global pandemic since February.
Japan considers making morning-after pill available without prescription
If a health ministry review goes well, the change could come next year.
Japan planning quickest-ever approval for anti-viral drug Avigan
According to sources, the government had already mapped out the drug's approval process by the time a Fujifilm unit disclosed data from clinical studies.
AstraZeneca's Japanese COVID-19 vaccine trial back on, but U.S. still paused
The British drugmaker said the early-to-mid-stage trial for the vaccine against the coronavirus resumed in Japan after consultations with the national health regulator
How Russia shortened the COVID-19 vaccine race to declare victory
Russia’s version of America’s Operation Warp Speed vaccine project is located far from the Kremlin on a sleepy side street on the outskirts of Moscow. Tucked in a sandy-brick building with an office advertising medical tests and a dingy wooden door, it doesn’t look like ...
Johnson & Johnson’s vaccine advances, sparking optimism in race
The company's vaccine could require just one shot instead of two — important considering that the entire population of the world needs vaccination.
Fujifilm completes delayed Avigan clinical test and looks to government application
Fujifilm Holdings Corp. said Monday it has completed delayed clinical tests of Avigan, a potential treatment for COVID-19, paving the way for the application of sales and production of the antivirus drug. Fujifilm Toyama Chemical Co., a subsidiary of Fujifilm Holdings, is conducting analysis of ...
Japan is forced to look abroad in the hunt for a COVID-19 vaccine. But at what cost?
Japan has a history of vaccines and related medical treatments that have proven to be problematic — take the prescription drug Tamiflu, for example.
COVID-19 vaccine leaders make trial plans public in transparency push
The moves come amid increasing concern that the effort to develop a COVID-19 vaccine is becoming politicized.
Pfizer COVID-19 vaccine trial reports no major safety issues
Safety has been a paramount concern since AstraZeneca paused tests of the vaccine it's co-developing with the University of Oxford following an adverse event in a U.K.